Results 301 to 310 of about 22,374,088 (435)

Molecular Cytogenetic Analysis of Prostatic Adenocarcinomas from Screening Studies [PDF]

, 2001
Janneke C. Alers, Pieter-Jaap Krijtenburg, André N. Vis, Robert F. Hoedemaeker, Mark F. Wildhagen, Wim C.J. Hop, Theodorus van der Kwast, Fritz H. Schröder, Hans J. Tanke, Herman van Dekken   +9 more
openalex   +1 more source

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm

British Journal of Haematology, Volume 206, Issue 4, Page 1121-1128, April 2025.
Outcomes with olutasidenib appear appreciably better than previous reports of other therapies for blast‐phase myeloproliferative neoplasm (MPN), supporting the role for olutasidenib‐based therapy in mIDH1 AML secondary to MPN. Summary Acute myeloid leukaemia (AML) arising from a myeloproliferative neoplasm (MPN) is more aggressive and less responsive ...
Stéphane De Botton, Christian Récher, Jorge Cortes, Antonio Curti, Pierre Fenaux, Pierre Peterlin, Arnaud Pigneux, Karen Yee, Andrew Wei, Alice Mims, Gary Schiller, Mwe Mwe Chao, Hua Tian, Justin M. Watts   +13 more
wiley   +1 more source

Cytogenetic Analysis of 570 Couples with Recurrent Pregnancy Loss: Reporting 11 Years of Experience. [PDF]

J Hum Reprod Sci, 2020
Alibakhshi R, Nejati P, Hamani S, Mir-Ahadi N, Jalilian N.   +4 more
europepmc   +1 more source

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials [PDF]

, 2001
Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew, G Harrison, Stephen E. Langabeer, Andrea A. Belton, Helen M. Walker, Keith Wheatley, David Bowen, Alan K. Burnett, Anthony H. Goldstone, David C. Linch   +11 more
openalex   +1 more source

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome

British Journal of Haematology, Volume 206, Issue 4, Page 1109-1120, April 2025.
Summary Germline variants in DDX41 (DDX41MT‐germline predisposition syndrome [GPS]) are associated with predisposition to haematological malignancies (HM), including lymphoid and myeloid neoplasms (MN). We retrospectively analysed the clinical and molecular features of 195 patients diagnosed and treated at Mayo Clinic with DDX41MT‐GPS.
Yael Kusne, Talha Badar, Terra Lasho, Ludovica Marando, Abhishek A. Mangaonkar, Christy Finke, James M. Foran, Aref Al‐Kali, Jeanne Palmer, Cecilia Arana Yi, Hassan B. Alkhateeb, Naseema Gangat, David Viswanatha, Mark R. Litzow, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik   +16 more
wiley   +1 more source

Outcomes of daratumumab–bortezomib–thalidomide–dexamethasone in treatment‐naive systemic AL amyloidosis

British Journal of Haematology, Volume 206, Issue 4, Page 1141-1148, April 2025.
Summary Systemic light chain (AL) amyloidosis is an incurable disorder caused by extra‐cellular deposition of light‐chain aggregates in critical organs. An immunomodulatory agent‐based quadruplet including anti‐CD38 therapy has not been investigated as a first‐line treatment in AL amyloidosis.
Jahanzaib Khwaja, Sriram Ravichandran, Oliver Cohen, Darren Foard, May Low, Ana Martinez‐Naharro, Lucia Venneri, Marianna Fontana, Philip N. Hawkins, Julian Gillmore, Helen J. Lachmann, Carol Whelan, Shameem Mahmood, Ashutosh Wechalekar   +13 more
wiley   +1 more source

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial [PDF]

, 2001
David Grimwade
openalex   +1 more source

The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML

British Journal of Haematology, Volume 206, Issue 5, Page 1373-1379, May 2025.
Summary IKZF1 mutations are recurrent alterations in acute myeloid leukaemia (AML), and hotspot point mutation, N159S, has recently been associated with unique gene expression and adverse risk. To better understand the molecular and clinical associations of IKZF1 N159S‐mutated AML, we performed a pooled analysis of 4136 AML patients.
Sebastian Stasik, Jan‐Niklas Eckardt, Christoph Röllig, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Carsten Müller‐Tidow, Kerstin Schäfer‐Eckart, Martin Kaufmann, Stefan W. Krause, Tim Sauer, Mathias Hänel, Andreas Neubauer, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede, on behalf of the Study Alliance Leukemia (SAL)   +18 more
wiley   +1 more source

Microfluidic Device for On-Chip Immunophenotyping and Cytogenetic Analysis of Rare Biological Cells. [PDF]

Cells, 2020
M Weerakoon-Ratnayake K, Vaidyanathan S, Larky N, Dathathreya K, Hu M, Jose J, Mog S, August K, K Godwin A, L Hupert M, A Witek M, A Soper S.   +11 more
europepmc   +1 more source

Cytogenetic analysis of miscarriages of couples with recurrent miscarriage: a case-control study. [PDF]

, 2001
Khalid Awartani, Wendy P. Robinson, Mary D. Stephenson   +2 more
openalex   +1 more source